MIMEDX to Participate at the Jefferies Virtual Healthcare Conference
May 27, 2021 08:00 ET
|
MiMedx Group, Inc
MARIETTA, Ga., May 27, 2021 (GLOBE NEWSWIRE) -- MIMEDX Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), an industry leader in utilizing amniotic tissue as a platform for regenerative...
MIMEDX Reminds Shareholders to Pre-Register for the Upcoming Virtual 2021 Annual Meeting of Shareholders
May 25, 2021 08:30 ET
|
MiMedx Group, Inc
Deadline to Pre-Register Extended to May 26, 2021 at 10:00 a.m. Eastern Pre-Registration Required to Attend Annual Meeting Visit www.votemimedx.com for Instructions on How to Pre-Register ...
MIMEDX Reminds Shareholders to Vote at the Upcoming Annual Meeting
May 12, 2021 08:00 ET
|
MiMedx Group, Inc
Vote FOR MIMEDX’s Experienced and Highly Qualified Directors and Governance Enhancement Proposals MARIETTA, Ga., May 12, 2021 (GLOBE NEWSWIRE) -- MIMEDX Group, Inc. (NASDAQ: MDXG) (“MIMEDX” or the...
MIMEDX to Participate at Upcoming Investor Conferences
May 10, 2021 08:00 ET
|
MiMedx Group, Inc
MARIETTA, Ga., May 10, 2021 (GLOBE NEWSWIRE) -- MIMEDX Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), an industry leader in utilizing amniotic tissue as a platform for regenerative...
MIMEDX Announces Collaborative Agreement with the Wake Forest Institute for Regenerative Medicine
May 06, 2021 08:00 ET
|
MiMedx Group, Inc
Relationship Furthers Mutual Interest in the Development and Advancement of Scientific Evidence to Support Safe and Effective Clinical Therapies MARIETTA, Ga., May 06, 2021 (GLOBE NEWSWIRE) --...
MIMEDX Urges Shareholders to Consider Prescience Point’s Motivations Before Voting Their Shares at the Company’s Annual Meeting
May 04, 2021 09:15 ET
|
MiMedx Group, Inc
Questions Every Shareholder Should Ask Prescience Point Prescience Point’s Trading History Tells the Real Story MARIETTA, Ga., May 04, 2021 (GLOBE NEWSWIRE) -- MIMEDX Group, Inc. (NASDAQ: MDXG)...
MIMEDX Files Definitive Proxy Materials and Mails Letter to Shareholders Highlighting Actions Taken to Transform MIMEDX and Drive Significant Value for Shareholders
May 03, 2021 08:02 ET
|
MiMedx Group, Inc
Urges Shareholders to Vote the WHITE Proxy Card “FOR ALL” Four of MIMEDX’s Director Nominees – Dr. Kathleen Behrens, Mr. Todd Newton, Mr. Timothy Wright, and Dr. Phyllis Gardner Entirely...
MiMedx Announces First Quarter 2021 Financial and Operating Results
April 28, 2021 17:00 ET
|
MiMedx Group, Inc
First Quarter Net Sales of $60.0 Million Advancing Innovative Late-Stage Musculoskeletal Pipeline with Data Readouts Expected in Q3 2021 Company to Host Conference Call on April 29, 2021 at 8:30 AM...
MiMedx Welcomes Dirk Stevens, Ph.D., as Senior Vice President, Quality Assurance and Regulatory Affairs
April 28, 2021 10:21 ET
|
MiMedx Group, Inc
Accomplished Regulatory Leader Joins MiMedx Management Team MARIETTA, Ga., April 28, 2021 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MiMedx” or “the Company”), an industry leader in...
MiMedx to Host First Quarter 2021 Operating and Financial Results Conference Call on April 29
April 22, 2021 08:00 ET
|
MiMedx Group, Inc
MARIETTA, Ga., April 22, 2021 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MiMedx” or the “Company”), an industry leader in utilizing amniotic tissue as a platform for regenerative...